Expanding the use of patient navigation: health coaching-based navigation as a novel approach to addressing deficits in breast cancer survivorship support Bridget A. OppongRuvarashe P. RumanoElectra D. Paskett Editorial 25 January 2024 Pages: 1 - 3
Neoadjuvant endocrine treatment in hormone receptor-positive breast cancer: Does it result in more breast-conserving surgery? Merel E. van de LooLayla AndourMarieke E. Straver Review 24 January 2024 Pages: 5 - 16
The association of PD-L1 expression and CD8-positive T cell infiltration rate with the pathological complete response after neoadjuvant treatment in HER2-positive breast cancer Kenan ÇetinŞermin KöktenÜlkan Kılıç Preclinical study Open access 25 January 2024 Pages: 17 - 27
Poziotinib treatment in patients with HER2-positive advanced breast cancer who have received prior anti-HER2 regimens Azadeh NasrazadaniJuan Luis Gomez MartiAdam Brufsky Clinical trial 23 January 2024 Pages: 29 - 37
Real-world use of multigene signatures in early breast cancer: differences to clinical trials Luca LicataRita De SanctisGiampaolo Bianchini Clinical trial Open access 24 January 2024 Pages: 39 - 48
Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trials Harriet JohanssonFederica BellerbaBernardo Bonanni Clinical trial Open access 26 January 2024 Pages: 49 - 59
Randomized placebo-controlled, double-blind clinical trial of nanoemulsion curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP pilot trial Maryam LustbergPatty Fan-HavardLisa D. Yee Clinical trial Open access 27 January 2024 Pages: 61 - 73
Effects of physical exercise during adjuvant chemotherapy for breast cancer on long-term tested and perceived cognition: results of a pragmatic follow-up study Willeke R. NaaktgeborenEmmie W. KoevoetsAnne M. May Clinical trial Open access 29 January 2024 Pages: 75 - 86
Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial Noortje VerschoorManouk K. BosJohn W. M. Martens Clinical trial Open access 31 January 2024 Pages: 87 - 95
Deep learning-guided adjuvant chemotherapy selection for elderly patients with breast cancer Enzhao ZhuLinmei ZhangZisheng Ai Clinical trial 31 January 2024 Pages: 97 - 107
Investigating the role of tumour-to-skin proximity in predicting nodal metastasis in breast cancer Thiviya SivakanthanJ. TannerA. Agrawal Clinical trial Open access 03 February 2024 Pages: 109 - 116
Comparison of long-term oncological outcomes after central lumpectomy versus nipple-sparing breast-conserving surgery for centrally located breast cancer: a propensity score-matched study Yung-Huyn HwangTae-Kyung YooByung Ho Son Clinical trial 08 February 2024 Pages: 117 - 125
Omission of axillary lymph node dissection for breast cancer patients with three or more positive sentinel lymph nodes Saranya PrathibhaMcKenzie WhiteTodd M. Tuttle Epidemiology 28 January 2024 Pages: 127 - 133
Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain Susanne Fogh JørgensenSilje SagstadSisse Njor Epidemiology Open access 29 January 2024 Pages: 135 - 145
Information needs in breast reconstruction after mastectomy: a qualitative analysis of free-text responses from 2077 women Kim WuytsVicki DurstonVictoria White Epidemiology Open access 01 February 2024 Pages: 147 - 157
MRI-visualized T2 hyperintense breast lesions: identifying clinical and imaging factors linked to malignant biopsy outcomes Mary Beth BissellSareh KeshavarsiVivianne Freitas Epidemiology 02 February 2024 Pages: 159 - 168
Socio-cultural and financial issues against breast cancer screening behaviour among eligible Indian women: evidence for action Shibaji GuptaSharmistha Sinha GuptaSonu Goel Epidemiology 12 February 2024 Pages: 169 - 179
Exploration of MELK as a downstream of Del-1 and druggable targets in triple-negative breast cancer In Hee LeeSoo Jung LeeYee Soo Chae Original Laboratory Investigation 27 January 2024 Pages: 181 - 191
High tumor infiltrating lymphocytes are significantly associated with pathological complete response in triple negative breast cancer treated with neoadjuvant KEYNOTE-522 chemoimmunotherapy Sarah J. WoodYuan GaoXiaoxian Li Original Laboratory Investigation 30 January 2024 Pages: 193 - 199
Real-world treatment patterns and clinical outcomes in patients treated with eribulin after prior phosphoinositide 3-Kinase inhibitor treatment for metastatic breast cancer Ravi K. GoyalJingchuan ZhangPeter A. Kaufman Original Laboratory Investigation Open access 04 February 2024 Pages: 201 - 210